NCT01605331View on ClinicalTrials.gov

Safety and Efficacy of SR-hGH (Sustained-release Human Growth Hormone, Declage Inj.)

PHASE4CompletedINTERVENTIONAL

Enrollment

132

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions

Growth Hormone Deficiency

Interventions

DRUG

sustained-release recombinant human GH (SR-rhGH)

Sponsors

Lead Sponsor

LG Life Sciences

All Listed Sponsors

lead

LG Life Sciences

INDUSTRY

NCT01605331 - Safety and Efficacy of SR-hGH (Sustained-release Human Growth Hormone, Declage Inj.) | Biotech Hunter | Biotech Hunter